NEWS
Our Latest News
ARCHIMED acquires generative AI Diagnostics player Arkstone to support fight against infectious disease
Private equity healthcare specialist ARCHIMED acquired a majority stake in Arkstone Medical Solutions (Arkstone), a pioneer in infectious disease clinical guidance and antimicrobial stewardship based on machine learning (ML) and generative artificial intelligence (gen AI).
ARCHIMED’s NAMSA returns more than a third of investment
October
7,
2021
ARCHIMED backs Xpress Biologics, a leading provider of plasmid DNA for advanced therapy medicinal products
October
5,
2021
ARCHIMED’s NAMSA consolidates leadership in Medical Device Clinical Research, buying Clinlogix
August
2,
2021
368